| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |